EUVIMEDEUVIMED entdecken
Crossref

Grade group 4 prostate cancer without intraductal carcinoma on biopsy is more likely to be downgraded on prostatectomy than with intraductal carcinoma

Levent Trabzonlu, Thanchanok Chaiprasit, Andreas Kontosis, Maria Picken

Virchows Archiv · 2024-03 · 484 (3) · 517-520

DOI: 10.1007/s00428-024-03745-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Virchows Archiv, online erschienen am 25.01.2024. Verfasst von Levent Trabzonlu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Loyola University Medical Center, Maywood, IL, USA. leventtrabzonlu186@gmail.com. Hauptthemen laut MEDLINE: Carcinoma, Intraductal, Noninfiltrating, Prostatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we investigated the association between intraductal carcinoma of the prostate (IDCP) along with several histopathological features on prostate biopsy and downgrading of grade group 4 (GG4) prostate cancer (PCa) in patients with the highest grade tumor of GG4 PCa in at least one core. A total of 29 cases had the highest grade tumor of GG4 PCa and radical prostatectomy performed between 2016 and 2021. IDCP was detected in 11 out of 29 cases on biopsy. The cases without IDCP were more likely to be downgraded on prostatectomy than with IDCP, with statistical significance (88.9% vs 36.4%, p = 0.003). The proportions of the highest-grade tumors by length and cores involved, average numbers of PCa-positive cores, and mean patient's age did not differ between cases that were downgraded and not downgraded at prostatectomy. Our results suggest that the absence of IDCP on biopsy could be a predictor of downgrading at prostatectomy for patients with the highest grade tumor of GG4 PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Intraductal, NoninfiltratingProstatic NeoplasmsMaleHumansBiopsyProstatectomyProstateNeoplasm Grading

Stichwörter der Autor:innen

DowngradingGrade group 4Intraductal carcinomaProstate cancer

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Loyola University Medical Center, Maywood, IL, USA. leventtrabzonlu186@gmail.com.
  • Department of Pathology, Massachusetts General Hospital, Boston, MA, USA. leventtrabzonlu186@gmail.com.
  • Department of Pathology and Laboratory Medicine, Loyola University Medical Center, Maywood, IL, USA.

Zitieren

APA

Trabzonlu, L., Chaiprasit, T., Kontosis, A., & Picken, M. (2024). Grade group 4 prostate cancer without intraductal carcinoma on biopsy is more likely to be downgraded on prostatectomy than with intraductal carcinoma. Virchows Archiv, 484(3), 517-520. https://doi.org/10.1007/s00428-024-03745-4

Vancouver

Trabzonlu L, Chaiprasit T, Kontosis A, Picken M. Grade group 4 prostate cancer without intraductal carcinoma on biopsy is more likely to be downgraded on prostatectomy than with intraductal carcinoma. Virchows Archiv. 2024;484(3):517-520. doi:10.1007/s00428-024-03745-4

BibTeX
@article{Trabzonlu2024,
  author = {Trabzonlu, Levent and Chaiprasit, Thanchanok and Kontosis, Andreas and Picken, Maria},
  title = {Grade group 4 prostate cancer without intraductal carcinoma on biopsy is more likely to be downgraded on prostatectomy than with intraductal carcinoma},
  journal = {Virchows Archiv},
  year = {2024},
  volume = {484},
  number = {3},
  pages = {517--520},
  doi = {10.1007/s00428-024-03745-4}
}
Kostenlos starten →